MyHealth

Manage your account, request prescriptions, set up appointments & more.

LOG IN
Don't have an account
Contact Us

LUMINA

Trial

Clinical Trial Title

LUMINA

Trial Status

Open to Enrollment

Start Date

May 1, 2019

Trial Type

Ophthalmology

Specific Condition

Active, Non-Infectious Uveitis

Description

This is a Phase III study to assess the efficacy and safety of DE-109 440 µg every 2 months in subjects with active, non-infectious uveitis of the posterior segment of the eye.

There is a 6-month, single-arm, open-label period after completion of the 6-month double- masked, controlled period allows the evaluation of the efficacy and safety of intravitreal injection of DE-109 440 µg every 2 months for longer duration than appropriate for a placebo or sham control.


Eligibility Criteria

Ages Eligible for Study:  18 years and older

Sexes Eligible for Study:  All

Criteria

Inclusion Criteria:

Non-Infectious Active Uveitis of the Posterior Segment

Exclusion Criteria:

Females who are pregnant, nursing, or planning a pregnancy Confirmed or suspected infectious uveitis


IRB Number

10828

Principal Investigator Name

Sirichai Pasadhika, MD

Contact Name

Tammy Mayfield

Phone

503-413-7945

Contact Fax

503-413-6861

Contact E-Mail

tmayfiel@lhs.org

Last Updated: Thursday, November 7, 2019 03:50:38 PM